ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.
ICUI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Icu Medical Inc. To summarize, we found that Icu Medical Inc ranked in the 26th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for ICUI, they are:
The stock's equity weight, or the proportion of capital from equity relative to debt, is 100. Its equity weight surpasses that of 95.79% of free cash flow generating stocks in the Healthcare sector.
The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than merely 0.05% of the free cash flow producing stocks we're observing.
ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 55.86% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
ENTA, WAT, ILMN, XRAY, and A can be thought of as valuation peers to ICUI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
ICU Medical (ICUI) has entered into a long-term agreement with Grifols to distribute non-PVC/non-DEHP IV containers for 0.9% Sodium Chloride Injection, USP in the U.S.The new agreement will expand ICU Medical's non-PVC/non-DEHP offering to include 50 mL to 1000 mL container sizes; additionally, the company plans to distribute Grifols' Dextrose IV solutions...
SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term agreement with Grifols to distribute a full line of non-PVC/non-DEHP IV containers for 0.9% Sodium Chloride Injection, USP to customers in the United…
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]